<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03177499</url>
  </required_header>
  <id_info>
    <org_study_id>CHESS1702</org_study_id>
    <nct_id>NCT03177499</nct_id>
  </id_info>
  <brief_title>Virtual Imaging-based Early Portal Pressure Gradient (vePPG) (CHESS1702)</brief_title>
  <acronym>vePPG</acronym>
  <official_title>Virtual Imaging-based Early Portal Pressure Gradient (vePPG) After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Shijitan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>302 Hospital of PLA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Third Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xingtai People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Ditan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>PLA Army General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Third Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanfang Hospital of Southern Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Portal pressure gradient (PPG) above 12 mmHg after transjugular intrahepatic portosystemic
      shunt (TIPS) increases the risk of portal hypertension complications. Currently, a PPG
      reduction &lt;12 mmHg after TIPS is the most consistent threshold associated with almost
      complete protection from variceal bleeding and ascites. However, the measurement of PPG
      requires an invasive procedure. A recent study investigated the variations in PPG
      measurements collected at different time points after placement of TIPS and demonstrated that
      a time point of at least 24 hours after which PPG values were best maintained (early PPG). It
      is of great clinical value to propose that an immediate PPG measurement fail to accurately
      identify the risk of decompensated event. And early PPG would change the decision making for
      re-intervention or not. However, the repeated invasive examination is extremely difficult to
      follow in clinical practice worldwide. The prospective multicenter trial aims to assess the
      diagnostic performance of a virtual imaging-based early portal pressure gradient (vePPG)
      (investigational technology) from CT angiography and Doppler ultrasound with invasive early
      PPG measurement as reference. The study participants with portal hypertension will be
      prospectively recruited at 10 high-volume liver centers in China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Portal pressure gradient (PPG) above 12 mmHg after transjugular intrahepatic portosystemic
      shunt (TIPS) increases the risk of portal hypertension complications. Currently, a PPG
      reduction &lt;12 mmHg after TIPS is the most consistent threshold associated with almost
      complete protection from variceal bleeding and ascites. However, the measurement of PPG
      requires an invasive procedure. A recent study investigated the variations in PPG
      measurements collected at different time points after placement of TIPS and demonstrated that
      a time point of at least 24 hours after which PPG values were best maintained (early PPG). It
      is of great clinical value to propose that an immediate PPG measurement fail to accurately
      identify the risk of decompensated event. And early PPG would change the decision making for
      re-intervention or not. However, the repeated invasive examination is extremely difficult to
      follow in clinical practice worldwide. The prospective multicenter trial aims to assess the
      diagnostic performance of a virtual imaging-based early portal pressure gradient (vePPG)
      (investigational technology) from CT angiography and Doppler ultrasound with invasive early
      PPG measurement as reference. The study participants with portal hypertension will be
      prospectively recruited at 10 high-volume liver centers (Beijing Shijitan Hospital; 302
      Hospital of PLA; Nanfang Hospital, Southern Medical University; The Third Xiangya Hospital of
      Central South University; Xingtai People's Hospital; Affiliated Traditional Chinese Medicine
      Hospital, Southwest Medical University; First Affiliated Hospital, Sun Yat-Sen University;
      Beijing Ditan Hospital; PLA Army General Hospital; Third Affiliated Hospital, Sun Yat-Sen
      University) in China.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 24, 2017</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vePPG Numerical Correlation</measure>
    <time_frame>1 day</time_frame>
    <description>Correlation of vePPG numerical value with early PPG numerical value</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immediate PPG Numerical Correlation</measure>
    <time_frame>7 days</time_frame>
    <description>Correlation of immediate PPG numerical value with early PPG numerical value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic Performance of vePPG</measure>
    <time_frame>1 day</time_frame>
    <description>Accuracy, sensitivity, specificity, positive predictive value and negative predictive value of vePPG to determine re-intervention or not when compared to invasive early PPG as reference (PPG≥12mmHg)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hypertension, Portal</condition>
  <arm_group>
    <arm_group_label>Single arm study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive CT angiography, Doppler ultrasound, invasive PPG, and vePPG per protocol.
Intervention: Procedure: Invasive PPG</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Invasive PPG</intervention_name>
    <description>Invasive PPG obtained by means of catheterization.</description>
    <arm_group_label>Single arm study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients providing written informed consent

          -  Patients with portal hypertension and received the placement of TIPS

          -  Patients with invasive immediate PPG and early PPG measurement

          -  Has undergone &gt; 64 multi-detector row CT angiography and Doppler ultrasound within 3
             days prior to invasive early PPG measurement

        Exclusion Criteria:

          -  Any severe adverse events after TIPS placement

          -  Inability to adhere to study procedures

          -  Prior devascularization operation

          -  Has received a liver transplant

          -  Patients with known anaphylactic allergy to iodinated contrast

          -  Pregnancy or unknown pregnancy status

          -  Patient requires an emergent procedure

          -  Any active, serious, life-threatening disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fuquan Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Shijitan Hospital, Capital Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhiwei Li, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>302 Hospital of PLA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaolong Qi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Nanfang Hospital of Southern Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaolong Qi, MD</last_name>
    <phone>86-20-61641681</phone>
    <email>qixiaolong@vip.163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>302 Hospital of PLA</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhiwei Li, MD</last_name>
    </contact>
    <investigator>
      <last_name>Zhiwei Li, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Ditan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jun Cheng, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jun Cheng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Shijitan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fuquan Liu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Fuquan Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PLA Army General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juqiang Han, MD</last_name>
    </contact>
    <investigator>
      <last_name>Juqiang Han, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nanfang Hospital, Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianbo Zhao, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jianbo Zhao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaoshun He, MD</last_name>
    </contact>
    <investigator>
      <last_name>Xiaoshun He, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bo Liu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bo Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xingtai People's Hospital</name>
      <address>
        <city>Xingtai</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dengxiang Liu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Dengxiang Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hongwu Luo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hongwu Luo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University</name>
      <address>
        <city>Luzhou</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guangyan Si, MD</last_name>
    </contact>
    <investigator>
      <last_name>Guangyan Si, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1. Erratum in: Hepatology. 2017 Jul;66(1):304.</citation>
    <PMID>27786365</PMID>
  </reference>
  <reference>
    <citation>de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3.</citation>
    <PMID>26047908</PMID>
  </reference>
  <reference>
    <citation>Silva-Junior G, Turon F, Baiges A, Cerda E, García-Criado Á, Blasi A, Torres F, Hernandez-Gea V, Bosch J, Garcia-Pagan JC. Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension. Gastroenterology. 2017 May;152(6):1358-1365. doi: 10.1053/j.gastro.2017.01.011. Epub 2017 Jan 24.</citation>
    <PMID>28130066</PMID>
  </reference>
  <reference>
    <citation>Min JK, Leipsic J, Pencina MJ, Berman DS, Koo BK, van Mieghem C, Erglis A, Lin FY, Dunning AM, Apruzzese P, Budoff MJ, Cole JH, Jaffer FA, Leon MB, Malpeso J, Mancini GB, Park SJ, Schwartz RS, Shaw LJ, Mauri L. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA. 2012 Sep 26;308(12):1237-45.</citation>
    <PMID>22922562</PMID>
  </reference>
  <reference>
    <citation>Qi X, Li Z, Huang J, Zhu Y, Liu H, Zhou F, Liu C, Xiao C, Dong J, Zhao Y, Xu M, Xing S, Xu W, Yang C. Virtual portal pressure gradient from anatomic CT angiography. Gut. 2015 Jun;64(6):1004-5. doi: 10.1136/gutjnl-2014-308543. Epub 2014 Nov 14.</citation>
    <PMID>25398771</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2017</study_first_submitted>
  <study_first_submitted_qc>June 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2017</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanfang Hospital of Southern Medical University</investigator_affiliation>
    <investigator_full_name>Xiaolong Qi</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Portal pressure gradient</keyword>
  <keyword>Transjugular intrahepatic portosystemic shunt</keyword>
  <keyword>Virtual imaging-based portal pressure gradient</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

